Literature DB >> 7306463

Recent trends in empyema thoracis.

G F Benfield.   

Abstract

One hundred and twenty-three patients with empyema thoracis presenting between 1968 and 1978 were studied. The predominant cause was pneumonia, with thoracic and gastrooesophageal surgery as the other important predisposing factors. 99 patients had received antibiotics before hospital admission and organisms were isolated from the empyema of 62 of these (63%). Of the 62 patients with organisms 39 (63%) had previously received an antibiotic appropriate to the sensitivity of the pathogen. Staph. aureus, Str. pneumoniae and anaerobes were the organisms most frequently found in empyemata following pneumonia, whilst Gram-negative enteric bacilli, the most frequently isolated organisms, were the predominant pathogens in postoperative cases. Following treatment with antibiotics alone or with closed chest drainage 29% of empyemata resolved but another 64% required subsequent surgery. The former group had a mean duration of symptoms of 2.8 (SE +/- 0.8) weeks before hospital treatment whereas the surgically treated group had symptoms for a mean period of 8.3 (SE +/- 1.5) weeks. 83% of patients who required thoracotomy had a history of more than four weeks at the time of admission. Thirty-six deaths were recorded, 11 of which were attributable to the empyema, giving an empyema mortality-rate of 9%. We conclude that with widespread use of antibiotics the nature of empyemata has changed and that those now seen are more often refractory to closed chest drainage, particularly if the history prior to hospital admission is longer than four weeks.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306463     DOI: 10.1016/0007-0971(81)90023-1

Source DB:  PubMed          Journal:  Br J Dis Chest        ISSN: 0007-0971


  4 in total

1.  Analysis of thirty-seven cases of pleural empyema.

Authors:  J Meyerovitch; I Shohet; E Rubinstein
Journal:  Eur J Clin Microbiol       Date:  1985-06       Impact factor: 3.267

2.  Pleural empyema in infants and children: analysis of 298 cases.

Authors:  A O Adeyemo; O Adeyujigbe; O O Taiwo
Journal:  J Natl Med Assoc       Date:  1984-08       Impact factor: 1.798

3.  Streptococcus milleri pulmonary disease: a review and clinical description of 25 patients.

Authors:  C A Wong; F Donald; J T Macfarlane
Journal:  Thorax       Date:  1995-10       Impact factor: 9.139

4.  Iterative thoracentesis as first-line treatment of complicated parapneumonic effusion.

Authors:  Julien Letheulle; Pierre Tattevin; Lauren Saunders; Mallorie Kerjouan; Hervé Léna; Benoit Desrues; Yves Le Tulzo; Stéphane Jouneau
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.